COM:GALMEDPHARMA
Galmed Pharmaceuticals
- Stock
Last Close
2.80
22/11 21:00
Market Cap
1.82M
Beta: -
Volume Today
16.15K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -9.10M - | -10.62M 16.69% | -16.95M 59.60% | -12.30M 27.45% | -9.86M 19.86% | -20.46M 107.60% | -28.77M 40.61% | -32.47M 12.85% | -17.87M 44.97% | -6.91M 61.31% | |
depreciation and amortization | 9K - | 50K 455.56% | 169K 238% | 239K 41.42% | 387K 61.92% | 35K 90.96% | 39K 11.43% | 42K 7.69% | 35K 16.67% | 31K 11.43% | |
deferred income tax | -601K - | -920K 53.08% | -1.40M 51.85% | 164K 111.74% | 12K 92.68% | -114K 1,050% | -437K 283.33% | 84K 119.22% | |||
stock based compensation | 601K - | 970K 61.40% | 1.63M 67.84% | 1.39M 14.37% | 1.78M 27.91% | 2.23M 25.13% | 2.07M 7.40% | 1.89M 8.71% | 1.30M 31.28% | ||
change in working capital | -748K - | 986K 231.82% | 2.75M 179.11% | -1.40M 150.80% | -1.21M 13.81% | 3.44M 385.06% | 1.10M 67.95% | -2.45M 322.52% | -2.45M 0.04% | 132K 105.39% | |
accounts receivables | -149K - | -214K 43.62% | 95K 144.39% | 129K 35.79% | -63K 148.84% | -609K 866.67% | 15K 102.46% | -313K 2,186.67% | 300K 195.85% | 345K 15% | |
inventory | -91K - | 39K 142.86% | 81K 107.69% | 671K 728.40% | -142K 121.16% | 609K 528.87% | -15K 102.46% | 313K 2,186.67% | -300K 195.85% | ||
accounts payables | -480K - | 1.38M 388.33% | 863K 37.64% | -846K 198.03% | -462K 45.39% | 4.18M 1,005.84% | 1.05M 74.98% | -2.17M 307.74% | -2.31M 6.25% | -681K 70.53% | |
other working capital | -28K - | -223K 696.43% | 1.71M 868.16% | -1.35M 178.93% | -538K 60.21% | -750K 39.41% | 54K 107.20% | -275K 609.26% | -140K 49.09% | 468K 434.29% | |
other non cash items | 601K - | 1.06M 76.71% | 1.67M 57.44% | -167K 109.99% | -144K 13.77% | -63K 56.25% | -285K 352.38% | 13K 104.56% | 485K 3,630.77% | 612K 26.19% | |
net cash provided by operating activities | -9.24M - | -8.47M 8.30% | -12.13M 43.13% | -12.07M 0.51% | -9.02M 25.23% | -14.94M 65.54% | -26.29M 75.99% | -32.89M 25.13% | -18.50M 43.75% | -6.14M 66.83% | |
investments in property plant and equipment | -770K - | -159K 79.35% | -17K 89.31% | -21K 23.53% | -90K 328.57% | -12K 86.67% | -44K 266.67% | -11K 75% | -4K 63.64% | ||
acquisitions net | 8.25M - | -6M 172.76% | 6.08M - | 21.80M 258.60% | -24.94M 214.42% | -17.57K - | |||||
purchases of investments | -8.25M - | -26.54M 221.87% | -7.62M 71.31% | -3.87M 49.19% | -98.35M 2,441.90% | -94.41M 4.00% | -55.03M 41.71% | -13.57M 75.34% | -3.87M 71.46% | -7.83M 102.25% | |
sales maturities of investments | -2.25M - | 15.59M 794.30% | 13.96M 10.51% | 10.32M 26.01% | 38.42M 272.12% | 101.10M 163.13% | 71.61M 29.16% | 25.04M 65.03% | 21.44M 14.39% | 8.63M 59.73% | |
other investing activites | -6M - | 6M 200% | 13K 99.78% | 9K 30.77% | -6.08M 67,644.44% | -21.80M 258.60% | 24.94M 214.42% | -1K 100.00% | 17.57K 1,856.70% | ||
net cash used for investing activites | -9.02M - | -11.11M 23.18% | 6.34M 157.05% | 6.44M 1.70% | -60.02M 1,031.33% | 6.68M 111.13% | 16.54M 147.62% | 11.46M 30.68% | 17.56M 53.23% | 800K 95.44% | |
debt repayment | |||||||||||
common stock issued | 41.86M - | 4.48M - | 15.02M 235.28% | 79.15M 427.06% | 143K 99.82% | 707K 394.41% | 17.37M 2,356.58% | 70K 99.60% | 6.18M 8,735.71% | ||
common stock repurchased | |||||||||||
dividends paid | |||||||||||
other financing activites | 255K - | 530K 107.84% | 1.03M 93.77% | 143 99.99% | 61K 42,557.34% | ||||||
net cash used provided by financing activities | 41.86M - | 4.73M - | 15.55M 228.41% | 80.18M 415.70% | 143K 99.82% | 768K 437.06% | 17.37M 2,161.46% | 70K 99.60% | 6.18M 8,735.71% | ||
effect of forex changes on cash | |||||||||||
net change in cash | 23.60M - | -19.58M 182.97% | -1.06M 94.59% | 9.92M 1,037.11% | 11.14M 12.23% | -8.12M 172.87% | -8.98M 10.68% | -4.06M 54.78% | -868K 78.63% | 848K 197.70% | |
cash at beginning of period | 137K - | 23.74M 17,225.55% | 4.16M 82.49% | 3.10M 25.48% | 13.02M 320.44% | 24.16M 85.54% | 16.04M 33.59% | 7.06M 55.99% | 3.00M 57.54% | 2.13M 28.95% | |
cash at end of period | 23.74M - | 4.16M 82.49% | 3.10M 25.48% | 13.02M 320.44% | 24.16M 85.54% | 16.04M 33.59% | 7.06M 55.99% | 3.00M 57.54% | 2.13M 28.95% | 2.98M 39.81% | |
operating cash flow | -9.24M - | -8.47M 8.30% | -12.13M 43.13% | -12.07M 0.51% | -9.02M 25.23% | -14.94M 65.54% | -26.29M 75.99% | -32.89M 25.13% | -18.50M 43.75% | -6.14M 66.83% | |
capital expenditure | -770K - | -159K 79.35% | -17K 89.31% | -21K 23.53% | -90K 328.57% | -12K 86.67% | -44K 266.67% | -11K 75% | -4K 63.64% | ||
free cash flow | -10.01M - | -8.63M 13.76% | -12.15M 40.69% | -12.09M 0.48% | -9.11M 24.61% | -14.95M 64.04% | -26.33M 76.14% | -32.90M 24.96% | -18.50M 43.76% | -6.14M 66.84% |
All numbers in USD (except ratios and percentages)